- Recommendations for gynecologic cancer care during the COVID-19 pandemic
-
- KMID: 2511969
- J Gynecol Oncol.
- 2020 Jul;31(4):e69.
- doi: 10.3802/jgo.2020.31.e69
-
- CITED
-
- Close
- SHARE
-
- Close
- Gynecologic oncology at the time of COVID-19 outbreak
-
Bogani G, Brusadelli C, Guerrisi R, Lopez S, Signorelli M, Ditto A, Raspagliesi F
- KMID: 2511971
- J Gynecol Oncol.
- 2020 Jul;31(4):e72.
- doi: 10.3802/jgo.2020.31.e72
The World Health Organization (WHO) classified the novel coronavirus (i.e., coronavirus disease 2019 [COVID-19]) as a global public health emergency. COVID-19 threatens to curtail patient access to evidence-based treatment. Medicine... -
- CITED
-
- Close
- SHARE
-
- Close
- FIGO staging in ovarian carcinoma and histological subtypes
-
Kehoe S
- KMID: 2511970
- J Gynecol Oncol.
- 2020 Jul;31(4):e70.
- doi: 10.3802/jgo.2020.31.e70
-
- CITED
-
- Close
- SHARE
-
- Close
- Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists
-
Wang Y, Zhang S, Wei L, Lin Z, Wang X, Wang J, Hua K, Cui M, Wang J, Wang S, Di W, Wang Y, An R, Xi M, Guo R, Zhou Q, Xie X, Xue F
- KMID: 2511968
- J Gynecol Oncol.
- 2020 Jul;31(4):e68.
- doi: 10.3802/jgo.2020.31.e68
The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected... -
- CITED
-
- Close
- SHARE
-
- Close
- Economic burden and treatment patterns of gynecologic cancers in the United States: evidence from the Medical Expenditure Panel Survey 2007–2014
-
Yue X, Pruemer JM, Hincapie AL, Almalki ZS, Guo JJ
- KMID: 2511962
- J Gynecol Oncol.
- 2020 Jul;31(4):e52.
- doi: 10.3802/jgo.2020.31.e52
Objective: This study estimated nationally representative medical expenditures of gynecologic cancers, described treatment patterns and assessed key risk factors associated with the economic burden in the United States. Methods: A retrospective... -
- CITED
-
- Close
- SHARE
-
- Close
- SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells
-
Yue Y, Xia L, Xu S, Wang C, Wang X, Lu W, Xie X
- KMID: 2511957
- J Gynecol Oncol.
- 2020 Jul;31(4):e46.
- doi: 10.3802/jgo.2020.31.e46
Objective: As cancer stem cells (CSCs) are considered as the origin of tumor development, recurrence, and drug resistance, we aimed to explore the mechanism related to modulating stemness in CSCs,... -
- CITED
-
- Close
- SHARE
-
- Close
- Epithelial ovarian cancer: a review of preoperative imaging features indicating suboptimal surgery
-
Jeong SY, Kim TJ, Park BK
- KMID: 2511966
- J Gynecol Oncol.
- 2020 Jul;31(4):e57.
- doi: 10.3802/jgo.2020.31.e57
Epithelial ovarian cancer has been traditionally treated with cytoreductive surgery and chemotherapy. Optimal surgery is the key to improving the prognosis, and, thus, preoperative imaging should be carefully assessed to... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparing efficacy of high-dose rate brachytherapy versus helical tomotherapy in the treatment of cervical cancer
-
Kim S, Lee S, Hong JH, Park YJ, Song JY, Lee JK, Lee NW
- KMID: 2511954
- J Gynecol Oncol.
- 2020 Jul;31(4):e42.
- doi: 10.3802/jgo.2020.31.e42
Objective: Boost radiation using brachytherapy (BT) is a standard treatment for local disease control in concomitant chemoradiation therapy (CCRT) for advanced cervical cancer. However, it is associated with gastrointestinal and genitourinary... -
- CITED
-
- Close
- SHARE
-
- Close
- Stage III uterine serous carcinoma: modern trends in multimodality treatment
-
Li JY, Young MR, Huang G, Litkouhi B, Santin A, Schwartz PE, Damast S
- KMID: 2511964
- J Gynecol Oncol.
- 2020 Jul;31(4):e53.
- doi: 10.3802/jgo.2020.31.e53
Objective: To examine outcomes in a modern treatment era for stage III uterine serous carcinoma (USC). Methods: Fifty women were retrospectively identified as 2009 International Federation of Gynecology and Obstetrics stage... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of diagnostic accuracy between endometrial curettage and aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group study
-
Kim MK, Seong SJ, Park DC, Hong JH, Roh JW, Kang SB
- KMID: 2511961
- J Gynecol Oncol.
- 2020 Jul;31(4):e51.
- doi: 10.3802/jgo.2020.31.e51
Objective: To compare the diagnostic accuracy of dilatation and curettage (D&C) versus endometrial aspiration biopsy in follow-up evaluation of patients treated with progestin for endometrial hyperplasia (EH) Methods: A prospective... -
- CITED
-
- Close
- SHARE
-
- Close
- The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy
-
Wu X, Qin J, Shen T, Fei W, Chen L, Xie X, Lu W
- KMID: 2511950
- J Gynecol Oncol.
- 2020 Jul;31(4):e36.
- doi: 10.3802/jgo.2020.31.e36
Objective: To assess the outcomes and toxic effects of 5-day actinomycin D (Act-D) salvage therapy and to explore the predictors of Act-D resistance in patients with low-risk gestational trophoblastic neoplasia... -
- CITED
-
- Close
- SHARE
-
- Close
- Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma
-
Xiang M, Kidd EA
- KMID: 2511952
- J Gynecol Oncol.
- 2020 Jul;31(4):e39.
- doi: 10.3802/jgo.2020.31.e39
Objective: To better delineate optimal management of high-risk, early-stage endometrial cancer, as national guidelines permit substantial practice variations. Methods: Patients with International Federation of Gynecology and Obstetrics (FIGO) stage IB grade... -
- CITED
-
- Close
- SHARE
-
- Close
- A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma
-
Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Mikami M, Enomoto T, Katabuchi H, Aoki D
- KMID: 2511956
- J Gynecol Oncol.
- 2020 Jul;31(4):e45.
- doi: 10.3802/jgo.2020.31.e45
Objective: International Federation of Gynecology and Obstetrics (FIGO) staging for ovarian, fallopian tube, and peritoneal cancers was revised in 2014. The aim of this study is to clarify whether the... -
- CITED
-
- Close
- SHARE
-
- Close
- Incidence trends for epithelial peritoneal, ovarian, and fallopian tube cancer during 1999–2016: a retrospective study based on the Korean National Cancer Incidence Database
-
Shin W, Won YJ, Yoo CW, Lim J, Lim MC
- KMID: 2511965
- J Gynecol Oncol.
- 2020 Jul;31(4):e56.
- doi: 10.3802/jgo.2020.31.e56
Objective: Primary peritoneal cancer (PPC), ovarian cancer (OC), and fallopian tube cancer (FTC) are considered as a single disease group. As knowledge of the pathogenesis and clinical presentation of peritoneal,... -
- CITED
-
- Close
- SHARE
-
- Close
- Safety evaluation of abdominal trachelectomy in patients with cervical tumors ≥2 cm: a single-institution, retrospective analysis
-
Okugawa K, Yahata H, Sonoda K, Ohgami T, Yasunaga M, Kaneki E, Kato K
- KMID: 2511953
- J Gynecol Oncol.
- 2020 Jul;31(4):e41.
- doi: 10.3802/jgo.2020.31.e41
Objective: For oncologic safety, vaginal radical trachelectomy is generally performed only in patients with cervical cancers smaller than 2 cm. However, because inclusion criteria for abdominal trachelectomy are controversial, we... -
- CITED
-
- Close
- SHARE
-
- Close
- The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma
-
Kajiyama H, Suzuki S, Yoshikawa N, Tamauchi S, Shibata K, Kikkawa F
- KMID: 2511959
- J Gynecol Oncol.
- 2020 Jul;31(4):e47.
- doi: 10.3802/jgo.2020.31.e47
Objective: The impact of systematic retroperitoneal lymphadenectomy (SRL) remains controversial in patients with advanced ovarian clear-cell carcinoma (CCC) who are optimally debulked. Methods: Between 1986 and 2017, a total of 3,227... -
- CITED
-
- Close
- SHARE
-
- Close
